Transient Receptor Potential Vanilloid 1 (TRPV1) is a non-selective, Ca2+ permeable cation channel activated by noxious heat, and chemical ligands, such as capsaicin and resiniferatoxin (RTX). Many compounds have been developed that either activate or inhibit TRPV1, but none of them are in routine clinical practice. This review will discuss the rationale for antagonists and agonists of TRPV1 for pain relief and other conditions, and strategies to develop new, better drugs to target this ion channel, using the newly available high-resolution structures.
CITATION STYLE
Carnevale, V., & Rohacs, T. (2016, September 23). TRPV1: A target for rational drug design. Pharmaceuticals. MDPI AG. https://doi.org/10.3390/ph9030052
Mendeley helps you to discover research relevant for your work.